Maat Pharma
Latest round
- Series B
Last raised
- Jan 2021
Total raised
- $8.9M
Investors
- 3
About Maat Pharma
Founded in 2013 and headquartered in Lyon, France, Maat Pharma SA develops therapies focused on the microbiome to support cancer treatment.Maat Pharma specializes in developing innovative microbiome-based therapies aimed at enhancing cancer treatment. Their core product offerings include specialized treatments designed to restore microbiome function, thereby improving patient outcomes in oncology. Notable products include Xervyteg®, MaaT033, MaaT034, and MaaT03X, which target various cancer indications. These therapies are primarily positioned to serve healthcare professionals and oncologists, working within a framework that supports patients undergoing cancer treatments.40. The company generates revenue through direct partnerships with healthcare institutions, where its microbiome therapies are integrated into treatment regimens for cancer patients. Their business model involves B2B transactions, where healthcare providers order treatments for their patients, and potential subscription agreements for ongoing access to updated products and therapies. The company is actively designing new products targeted at improving outcomes in oncology and plans to expand its market reach into additional regions, particularly focusing on Europe and North America by 2023. This expansion will enhance their service offerings to healthcare professionals and oncologists in those markets.
Who invested in Maat Pharma
3 investors across 1 round
See all investors in Maat Pharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Jan 15, 2021
Amount
$8.9M
Investors
Questions about Maat Pharma
Who invested in Maat Pharma?
Maat Pharma has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Maat Pharma raised?
Maat Pharma has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Maat Pharma last raise money?
Maat Pharma's most recent round on record is a Series B, in Jan 2021.
What does Maat Pharma do?
Founded in 2013 and headquartered in Lyon, France, Maat Pharma SA develops therapies focused on the microbiome to support cancer treatment.
Where is Maat Pharma headquartered?
Maat Pharma is headquartered in Lyon, France.
Which VCs invest in companies like Maat Pharma?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Maat Pharma's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Maat Pharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.